Morning Briefing
Summaries of health policy coverage from major news organizations
FDA Opens Two-Day Hearing To Examine Safety Of Diabetes Drug Avandia
New York Times reports that drugmaker SmithKline Beecham conducted studies that pointed to heart risks from the drug, but the company did not notify officials or the public.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
